AVDL (AVDL)
Avadel Pharmaceuticals plc
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
IEAvadel Pharmaceuticals plc is a biopharmaceutical firm primarily conducting its operations within the United States.
The company's flagship investigational drug, FT218, a specialized compound of sodium oxybate, is currently in Phase 3 clinical trials. This therapeutic candidate aims to alleviate severe daytime somnolence and sudden muscle weakness (cataplexy) in adult individuals afflicted with narcolepsy. Established in 2015, the entity was formerly recognized as Flamel Technologies SA before rebranding as Avadel Pharmaceuticals plc in January 2017.
Its global headquarters are situated in Dublin, Ireland.
Leadership
Dr. Eric J. Ende
President at Ende BioMedical Consulting Group
Dr. Mark A. McCamish
President and Chief Executive Officer of IconOVir Bio, Inc.
Dr. Naseem S. Amin
Chief Executive Officer of Orphalan SA
Eric J. Ende, M.D.
Director
Employees
--
Country
IE
Sector
Healthcare
Website
investor.alkermes.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Weiss Asset Management LP | -- | Sale | 11.11M | $233.35M | Feb 13, 2026 |
 McCamish Mark Anthony | Director | Withholding/Transfer | 22.0K | $462.0K | Feb 12, 2026 |
| McCamish Mark Anthony | Director | Withholding/Transfer | 67.0K | $1.41M | Feb 12, 2026 |
 Glass Geoffrey Michael | Director | Withholding/Transfer | 22.0K | $462.1K | Feb 12, 2026 |
| Glass Geoffrey Michael | Director | Withholding/Transfer | 69.1K | $1.45M | Feb 12, 2026 |
| Glass Geoffrey Michael | Director | Withholding/Transfer | 75.9K | $1.59M | Feb 12, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
BlackRock, Inc. · filed Jul 2025 | 6.7M | 7.0% | 13G |
JANUS HENDERSON GROUP PLC · filed Feb 2026 | 1.8M | 1.9% | 13G |
HUNTINGTON NATIONAL BANK | 1 | -- | 13F |
Insiders
- Weiss Asset Management LP
- McCamish Mark AnthonyDirector
- Glass Geoffrey MichaelDirector
- Ende Eric JDirector
- Divis Gregory JChief Executive Officer
- Amin NaseemDirector
- MCHUGH THOMAS SChief Financial Officer
- Thornton Peter J.Director
- Seurer Jerad G.Gen. Counsel & Corp. Secretary
- Palczuk LindaDirector
Top institutional holders
IE30d Avg
--
60d Avg
--
90d Avg
--